Literature DB >> 26813704

Differential diagnosis between primary lung squamous cell carcinoma and pulmonary metastasis of head and neck squamous cell carcinoma.

Junji Ichinose1, Aya Shinozaki-Ushiku2, Daiya Takai3, Masashi Fukayama2, Jun Nakajima1.   

Abstract

Differentiation between lung squamous cell carcinoma and pulmonary metastasis of head and neck squamous cell carcinoma is clinically important because the prognoses and therapeutic options are considerably different. However, the clinical, pathological, and immunohistochemical diagnostic methods have not yet been fully established. Although various molecular methods have been developed, they have not yet been practically applied. A combined approach involving molecular and immunohistochemical analysis, such as one that uses antibodies selected on the basis of comprehensive genetic analysis results, may be effective. We suggest a new diagnostic criteria using the clinical characteristics and the result of immunohistochemical analysis. However, there are two underlying problems in the development of new diagnostic methods: tumor heterogeneity and determination of the diagnostic accuracy.

Entities:  

Keywords:  Diagnosis; head and neck cancer; immunohistochemistry; lung cancer; metastasis; molecular analysis; pathology; squamous cell carcinoma; surgery

Mesh:

Year:  2016        PMID: 26813704     DOI: 10.1586/14737140.2016.1147352

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


  4 in total

1.  Clinical Application of Next-generation Sequencing for the Diagnosis of Lung Squamous Cell Carcinoma: Is It Primary or Secondary?

Authors:  Hiroaki Aizawa; Takahiro Karasaki; Kazuhiro Nagayama; Aya Shinozaki-Ushiku; Hiroyuki Aburatani; Hiroyuki Mano; Jun Nakajima
Journal:  Intern Med       Date:  2020-02-12       Impact factor: 1.271

2.  Comparative proteomics reveals a diagnostic signature for pulmonary head-and-neck cancer metastasis.

Authors:  Hanibal Bohnenberger; Lars Kaderali; Philipp Ströbel; Diego Yepes; Uwe Plessmann; Neekesh V Dharia; Sha Yao; Carina Heydt; Sabine Merkelbach-Bruse; Alexander Emmert; Jonatan Hoffmann; Julius Bodemeyer; Kirsten Reuter-Jessen; Anna-Maria Lois; Leif Hendrik Dröge; Philipp Baumeister; Christoph Walz; Lorenz Biggemann; Roland Walter; Björn Häupl; Federico Comoglio; Kuan-Ting Pan; Sebastian Scheich; Christof Lenz; Stefan Küffer; Felix Bremmer; Julia Kitz; Maren Sitte; Tim Beißbarth; Marc Hinterthaner; Martin Sebastian; Joachim Lotz; Hans-Ulrich Schildhaus; Hendrik Wolff; Bernhard C Danner; Christian Brandts; Reinhard Büttner; Martin Canis; Kimberly Stegmaier; Hubert Serve; Henning Urlaub; Thomas Oellerich
Journal:  EMBO Mol Med       Date:  2018-09       Impact factor: 12.137

3.  Quantitative proteomics identifies biomarkers to distinguish pulmonary from head and neck squamous cell carcinomas by immunohistochemistry.

Authors:  Annika Richter; Alexander Fichtner; Jasmin Joost; Hanibal Bohnenberger; Philipp Brockmeyer; Philipp Kauffmann; Henning Schliephake; Alexander Hammerstein-Equord; Stefan Kueffer; Henning Urlaub; Thomas Oellerich; Philipp Ströbel; Felix Bremmer
Journal:  J Pathol Clin Res       Date:  2021-10-14

4.  Discrimination Between Primary Lung Cancer and Lung Metastases by Genomic Profiling.

Authors:  Rumi Higuchi; Taichiro Goto; Takahiro Nakagomi; Yosuke Hirotsu; Toshio Oyama; Kenji Amemiya; Hitoshi Mochizuki; Masao Omata
Journal:  JTO Clin Res Rep       Date:  2021-11-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.